Physician

Vu Tran Ho, MD

According to 2025 Medicare claims, Vu Ho, MD (NPI: 1871574871) practices hematology/oncology in the St. Petersburg-Clearwater-Largo, FL market, with the plurality of this provider's patient population coming from Pinellas, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 33705-1420.

Ho's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 709 traditional Medicare patients, billed 290,490 HCPCS/CPT codes, and received $3,367,904 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,557 prescription claims across 313 beneficiaries totaling $5,086,001 in drug costs, led by Pomalyst (Pomalidomide). 2018 DME data shows 11 claims. Open Payments data shows 36 records totaling $848. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,490,447 to $3,367,904. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $837,607 to $5,086,001. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.7M$3.4M2015 Medicare payment: $1,490,447 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,751,819 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,107,008 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,913,870 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,869,399 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,995,330 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,004,181 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,560,530 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,625,416 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,367,904 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015766189,168$1,490,447
2016744193,783$1,751,819
2017735206,240$2,107,008
2018709249,396$2,913,870
2019753268,313$2,869,399
2020503239,683$2,995,330
2021462209,375$3,004,181
2022538205,770$2,560,530
2023508261,395$2,625,416
2024709290,490$3,367,904

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.5M$5.1M2015 Drug cost: $837,607 (USD; Tot_Drug_Cst)2016 Drug cost: $1,304,470 (USD; Tot_Drug_Cst)2017 Drug cost: $1,603,549 (USD; Tot_Drug_Cst)2018 Drug cost: $1,873,917 (USD; Tot_Drug_Cst)2019 Drug cost: $3,073,406 (USD; Tot_Drug_Cst)2020 Drug cost: $3,251,280 (USD; Tot_Drug_Cst)2021 Drug cost: $3,011,923 (USD; Tot_Drug_Cst)2022 Drug cost: $2,998,831 (USD; Tot_Drug_Cst)2023 Drug cost: $2,783,719 (USD; Tot_Drug_Cst)2024 Drug cost: $5,086,001 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151871,095$837,607
20162131,191$1,304,470
20171951,112$1,603,549
20181871,009$1,873,917
20191961,074$3,073,406
20201881,210$3,251,280
20211961,290$3,011,923
20222091,166$2,998,831
20232311,208$2,783,719
20243131,557$5,086,001

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$13K$26K2015 Medicare payment: $26,145 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $13,865 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $10,174 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $2,611 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R70$26,145
2016N/R98$13,865
2017N/R47$10,174
2018N/R11$2,611
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more263820$96
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more317472$63
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's235372$13
36415Insertion of needle into vein for collection of blood sample5371,631$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count5391,858$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
PomalystPomalidomide431,204$975,558
RevlimidLenalidomide34833$514,555
AyvakitAvapritinib12360$476,487
JakafiRuxolitinib Phosphate371,110$417,220
VerzenioAbemaciclib25700$363,292

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.36$848Gilead Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Vu Tran Ho, MD?

Tedicare shows public-source Medicare data for Vu Tran Ho, MD (NPI 1871574871), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vu Tran Ho, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Vu Tran Ho, MD?

Vu Tran Ho, MD is linked to FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (billing NPI 1760590962) in the available physician profile data.

Does Vu Tran Ho, MD have Open Payments data?

Vu Tran Ho, MD has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.